Home › Asset managers › Compare 2024-2025 › Equitable vs John Hancock
Equitable 2024-2025 · John Hancock 2024-2025 · Download the item list (CSV)
| Common items | Same | Differ | Split (not in %) | Same position | Fund-level | |
|---|---|---|---|---|---|---|
| All ballot items | 13,157 | 10,803 | 230 | 2,124 | 97.9% | 92.5% |
| Board proposals | 10,622 | 8,812 | 215 | 1,595 | 97.6% | 92.7% |
| E&S shareholder proposals | 245 | 91 | 0 | 154 | 100.0% | 79.4% |
| Other items | 2,290 | 1,900 | 15 | 375 | 99.2% | 93.0% |
Everything Voted differently Split votes
All ballot items Board proposals E&S shareholder proposals Other items
215 items. “Voted differently”: each manager’s funds all voted one way, and the two ways differ. “Split”: at least one manager’s funds did not all vote the same way.
| Company | Meeting | Proposal | On the ballot from | Board recommended | Equitable | John Hancock |
|---|---|---|---|---|---|---|
| THE TORONTO-DOMINION BANK | April 10, 2025 | ELECTION OF DIRECTOR: S. JANE ROWE Director Elections |
Board | For | WITHHOLD 1 fund |
ABSTAIN 3 funds |
| TMX GROUP LIMITED | May 6, 2025 | ELECTION OF DIRECTOR: MONIQUE MERCIER Director Elections |
Board | For | WITHHOLD 1 fund |
FOR 2 funds |
| TREDEGAR CORP. | May 8, 2025 | Non-Binding Advisory Vote to Approve Named Executive Officer Compensation Say-on-Pay |
Board | For | FOR 9 funds |
AGAINST 6 funds |
| UBS GROUP AG | April 10, 2025 | ELECT RENATA BRUENGGER AS DIRECTOR Director Elections |
Board | For | FOR 9 funds |
AGAINST 5 funds |
| ULTRALIFE CORP. | July 16, 2024 | To approve the adoption of the Ultralife Corporation 2024 Long-Term Incentive Plan. Compensation |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| VENTYX BIOSCIENCES INC. | June 4, 2025 | To approve, on an advisory basis, the compensation of the named executive officers identified in the 2024 Summary Compensation Table in the "Executive Compensation" section of the proxy statement (the "Say-on-Pay Vote"). Say-on-Pay |
Board | For | FOR 8 funds |
AGAINST 5 funds |
| VERACYTE INC. | June 17, 2025 | The approval of an amendment to our Veracyte, Inc. 2023 Equity Incentive Plan. Compensation |
Board | For | FOR 8 funds |
AGAINST 5 funds |
| VIKING THERAPEUTICS INC | May 20, 2025 | TO APPROVE, ON AN ADVISORY BASIS, THE COMPENSATION OF OUR NAMED EXECUTIVE OFFICERS. Say-on-Pay |
Board | For | FOR 4 funds |
AGAINST 3 funds |
| VISTAGEN THERAPEUTICS INC. | August 26, 2024 | To approve, on a non-binding advisory basis, the compensation paid to the Company's Named Executive Officers. Say-on-Pay |
Board | For | FOR 1 fund |
AGAINST 2 funds |
| VOXX INTERNATIONAL CORP. | March 31, 2025 | To approve by a non-binding, advisory vote certain compensation arrangements for the Company's named executive officers in connection with the Merger. Say-on-Pay |
Board | For | FOR 2 funds |
AGAINST 3 funds |
| WESTWOOD H | April 30, 2025 | To approve the Eleventh Amended and Restated Westwood Holdings Group, Inc. Stock Incentive Plan. Compensation |
Board | Not determined | FOR 1 fund |
AGAINST 1 fund |
| WHITESTONE REIT | May 15, 2025 | To approve an amendment to the 2018 Long-Term Equity Incentive Ownership Plan. Compensation |
Board | For | FOR 7 funds |
AGAINST 3 funds |
| WRAP TECHNOLOGIES INC. | December 23, 2024 | To approve a proposed amendment to the Wrap Technologies, Inc. 2017 Equity Compensation Plan, as amended, to increase the aggregate number of shares available for the grant of awards by 7,500,000 shares, to a total of 16,500,000 shares of common stock of the Company, par value $0.0001 per share, and Compensation |
Board | For | FOR 1 fund |
AGAINST 1 fund |
| XENIA HOTELS & RESORTS INC. | May 13, 2025 | To approve an amendment to the 2015 Incentive Award Plan to increase the number of shares that may be issued thereunder. Compensation |
Board | For | FOR 8 funds |
AGAINST 3 funds |
| XOMA ROYALTY CORP. | May 28, 2025 | Approval of the Amended and Restated 2010 Long Term Incentive and Stock Award Plan. Compensation |
Board | For | FOR 8 funds |
AGAINST 3 funds |
← Previous Page 3 of 3
How items are matched and positions counted: see the comparison table and the methodology. Built October 18, 2026 from SEC Form N-PX filings.